The effectiveness of multiple atelocollagen injection in partial thickness rotator cuff tear

The Catholic University of Korea, Seoul St. Mary's Hospital0 个研究点目标入组 40 人开始时间: 待定最近更新: 2024年3月4日

试验速览

暂无简介。

•Inclusion Criteria
•1)Adults over 30 and under 70
•2)Partial thickness rotator cuff tear diagnosed by imaging test (ultrasound or MRI)
•3)Patients who have been treated for more than 3 months by medication or physical therapy but have not improved
•4)If the concomitant medication continues to be administered during the trial, patients who have confirmed the correct prescription drug being taken within at least one week and agreed to maintain a constant amount as before injection during the study
•5)patients who understand the study, agree to participate in the study, and have their own written consent

•Exclusion Criteria
•1)Patients with previous history of injection therapy within 6 weeks
•2)Patients with Adhesive capsulitis
•3)Full thickness rotator cuff tears diagnosed by MRI or ultrasound
•4)Patients with a history of uncontrolled diabetes, infectious arthritis, rheumatoid arthritis, tumors, fractures, degenerative arthritis
•5)Patients who refuse injection
•6)Patients who want surgical treatment
•7)Patients with hypersensitivity to collagen
•8)Pregnant or lactating or planning to become pregnant
•9)Patients expected to have complications because of anticoagulants therapy
•10)Patients sensitive to pig protein
•11)Patients with a history of radiotherapy and chemotherapy within the past 2 years (except when it is determined that collagen can be administered as judged by a clinician)
•12)Patients or family members with autoimmune disease in progress or with past military service
•13)Patients who are sensitive to implants
•14)Any clinically significant health abnormalities that can affect the completion of the study
•15)Patients deemed inappropriate for this study by the judgment of doctor such as mental illness

发起方